Encore Medical, Inc. (EMI)
| Market Cap | 48.72M |
| Revenue (ttm) | 2.10M |
| Net Income (ttm) | -1.58M |
| Shares Out | 9.74M |
| EPS (ttm) | -0.16 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | n/a |
| Previous Close | n/a |
| Day's Range | n/a |
| 52-Week Range | n/a |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About EMI
Encore Medical is a structural heart device company dedicated to the transcatheter closure of certain cardiac defects.We develop, manufacture, and market septal occlusion products, which are small, implantable devices delivered through a catheter inserted into a major blood vessel to permanently repair certain cardiac defects. Our devices include patented technology that has been in use extensively outside of the U.S. Procedures are performed in a cardiac catheterization lab and reduce the need for open heart surgery or a lifetime of drug thera... [Read more]
Financial Performance
Financial StatementsNews
Cardiac implant developer Encore Medical files for a $17 million IPO
Encore Medical, which makes transcatheter implants to repair cardiac defects, filed on Monday with the SEC to raise up to $17 million in an initial public offering.
Encore Medical IPO Registration Document (S-1)
Encore Medical has filed to go public with an IPO on the NYSE American.